β-CTX

2 papers2 findings

Human trial1
Animals1

Interventions

2

Liraglutide

downin humans1

1 study

Liraglutide decreases β-CTX in humans.
Human trialin diabetic osteoporosis patients receiving zoledronic acid and calcium carbonate and vitamin D3n = 99
Liraglutide in combination with zoledronic acid and calcium carbonate and vitamin D3 for diabetic osteoporosis: efficacy and glycometabolism impact
American journal of translational research15 Aug 2026

More on Liraglutide

Liuwei dihuang wan

downin mice1

1 study

Liuwei dihuang wan decreases β-CTX in mice.
Animalsin OVX mice9.75 g/kg/day8 weeksfemales
Liuwei Dihuang Wan Inhibits Osteoclastogenesis and Ovariectomy-Induced Bone Loss by Suppressing NF-κB Signaling
Journal of visualized experiments : JoVE28 Jul 2026

More on Liuwei dihuang wan

Latest

2 in 12 months

American Journal of Translational Research22 Sep

Liraglutide in combination with zoledronic acid and calcium carbonate and vitamin D3 for diabetic osteoporosis: efficacy and glycometabolism impact

Non-randomised trial in 99 peopleLiraglutide

Journal of Visualized Experiments18 Aug

Liuwei Dihuang Wan Inhibits Osteoclastogenesis and Ovariectomy-Induced Bone Loss by Suppressing NF-κB Signaling

Experiments in 27 miceBones and joints

Acta Endocrinologica9 Aug

EFFECTS OF LIRAGLUTIDE ON BONE TURNOVER MARKERS AND BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Randomised trial in 100 peopleLiraglutide